Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)

K.L. Nathanson; A.-M. Martin; B. Wubbenhorst; J. Greshock; R. Letrero; K. D'Andrea; S. O'Day; J.R. Infante; G.S. Falchook; H.-T. Arkenau; Michael Millward; M.P. Brown; A. Pavlick; M.A. Davies; B. Ma; R. Gagnon; M. Curtis; P.F. Lebowitz; R. Kefford; G.V. Long

doi:10.1158/1078-0432.CCR-13-0827

Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)

K.L. Nathanson, A.-M. Martin, B. Wubbenhorst, J. Greshock, R. Letrero, K. D'Andrea, S. O'Day, J.R. Infante, G.S. Falchook, H.-T. Arkenau, Michael Millward, M.P. Brown, A. Pavlick, M.A. Davies, B. Ma, R. Gagnon, M. Curtis, P.F. Lebowitz, R. Kefford, G.V. Long

Research output: Contribution to journal › Article › peer-review

148 Citations (Scopus)

Original language	English
Pages (from-to)	4868-4878
Journal	Clinical Cancer Research
Volume	19
Issue number	17
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-0827
Publication status	Published - 2013

Access to Document

10.1158/1078-0432.CCR-13-0827

Cite this

Nathanson, K. L., Martin, A.-M., Wubbenhorst, B., Greshock, J., Letrero, R., D'Andrea, K., O'Day, S., Infante, J. R., Falchook, G. S., Arkenau, H.-T., Millward, M., Brown, M. P., Pavlick, A., Davies, M. A., Ma, B., Gagnon, R., Curtis, M., Lebowitz, P. F., Kefford, R., & Long, G. V. (2013). Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436). Clinical Cancer Research, 19(17), 4868-4878. https://doi.org/10.1158/1078-0432.CCR-13-0827

@article{e39135d9a14a432d827e8b7b18b09570,

title = "Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)",

author = "K.L. Nathanson and A.-M. Martin and B. Wubbenhorst and J. Greshock and R. Letrero and K. D'Andrea and S. O'Day and J.R. Infante and G.S. Falchook and H.-T. Arkenau and Michael Millward and M.P. Brown and A. Pavlick and M.A. Davies and B. Ma and R. Gagnon and M. Curtis and P.F. Lebowitz and R. Kefford and G.V. Long",

year = "2013",

doi = "10.1158/1078-0432.CCR-13-0827",

language = "English",

volume = "19",

pages = "4868--4878",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "17",

}

Nathanson, KL, Martin, A-M, Wubbenhorst, B, Greshock, J, Letrero, R, D'Andrea, K, O'Day, S, Infante, JR, Falchook, GS, Arkenau, H-T, Millward, M, Brown, MP, Pavlick, A, Davies, MA, Ma, B, Gagnon, R, Curtis, M, Lebowitz, PF, Kefford, R & Long, GV 2013, 'Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)', Clinical Cancer Research, vol. 19, no. 17, pp. 4868-4878. https://doi.org/10.1158/1078-0432.CCR-13-0827

TY - JOUR

T1 - Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)

AU - Nathanson, K.L.

AU - Martin, A.-M.

AU - Wubbenhorst, B.

AU - Greshock, J.

AU - Letrero, R.

AU - D'Andrea, K.

AU - O'Day, S.

AU - Infante, J.R.

AU - Falchook, G.S.

AU - Arkenau, H.-T.

AU - Millward, Michael

AU - Brown, M.P.

AU - Pavlick, A.

AU - Davies, M.A.

AU - Ma, B.

AU - Gagnon, R.

AU - Curtis, M.

AU - Lebowitz, P.F.

AU - Kefford, R.

AU - Long, G.V.

PY - 2013

Y1 - 2013

U2 - 10.1158/1078-0432.CCR-13-0827

DO - 10.1158/1078-0432.CCR-13-0827

M3 - Article

SN - 1078-0432

VL - 19

SP - 4868

EP - 4878

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 17

ER -